eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
5/2018
vol. 14
 
Share:
Share:
more
 
 
abstract:
Basic research

What should we focus on before preimplantation genetic diagnosis/screening?

Zhong Zheng, Xiaoming Zhao, Bing Xu, Ning Yao

Arch Med Sci 2018; 14, 5: 1119–1124
Online publish date: 2018/01/16
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Preimplantation genetic diagnosis/screening (PGD/PGS) can effectively detect chromosomal abnormalities in an embryo but only if an embryo is available. However, not all couples can obtain an embryo that is available for testing. The purpose of this study was to identify factors which might affect the formation of PGD/PGS embryos to predict the possibility of obtaining embryos that could be detected.

Material and methods
In a retrospective study, we included all couples who underwent PGD/PGS at our center from January 2015 to December 2016. We compared these patients according to the non-blastocyst group and the blastocyst group.

Results
There were 302 couples who had blastocysts in their first PGD/PGS cycle. Fifty-seven couples had no blastocysts in their PGD/PGS cycles: 43 couples had no blastocysts in one cycle; 10 in two cycles; 4 in three cycles. The non-blastocyst group was older than the blastocyst group (32.37 vs. 30.69, p = 0.048). Anti-mullerian hormone (AMH, ng/ml) in the non-blastocyst group was significantly lower than in the blastocyst group (4.80 ±3.67 vs. 3.07 ±2.30, p = 0.00). Women whose chromosome were aneuploid (47, XXX or 45, X) had a similar AMH level compared with others, but the number of retrieved oocytes was much lower; the normal karyotype was 14.25 and aneuploidy was 5.40 (p = 0.01) in women < 30 years old. There was the same condition in women aged 30–38 years (14.60 vs. 3.44, p < 0.001). Male’s different chromosome karyotype had no influence on double pronuclear number or the rate of blastocyst formation. Presence of endometriosis, polycystic ovary syndrome and tubal factor showed no difference between the blastocyst and non-blastocyst group. Nor did oligospermia and asthenospermia.

Conclusions
Elderly women, those with lower AMH and women with 47, XXX or 45, X have fewer ova, leading to the possibility of no blastocyst. These couples should be fully informed and weigh the advantages and disadvantages before undergoing PGD/PGS.

keywords:

aneuploidy, maternal age, anti-mullerian, preimplantation genetic screening, preimplantation genetic diagnosis

references:
Nich M, de Cassia Savio Frigueira R, de Almeida Ferreira Braga D, Souza Setti A, Iaconelli A Jr, Borges E Jr. Decreased fertility in poor responder women is not related to oocyte morphological status. Arch Med Sci 2011; 7: 315-20.
Cabry R, Merviel P, Hazout A, et al. Management of infertility in women over 40. Maturitas 2014; 78: 17-21.
Tsafir A, Simon A, Revel A, Reubinoff B, Lewin A, Laufer N. Retrospective analysis of 1217 IVF cycles in women aged 40 aged old and older. RBM online 2007; 14: 348-55.
Klipstein S, Regan M, Ryley D, Goldman M, Alper M, Reindollar R. One last chance for pregnancy: a review of 2705 in vitro fertilization cycles initiated in women age 40 years and above. Fertil Steril 2005; 84: 435-45.
Ron-El R, Raziel A, Strassburger D, Schachter M, Kasterstein E, Friedler S. Outcome of assisted reproductive technology in women over the age of 41. Fertil Steril 2000; 74: 471-5.
Ciray HN, Ulug U, Tosun S, Erden HF, Bahceci M. Outcome of 1114 ICSI and embryo transfer cycles of women 40 years of age and over. Reprod Biomed Online 2006; 13: 516-22.
Suchartwatnachai C, Wongkularb A, Srisombut C, Choktanasiri W, Chinsomboon S, Rojanasakul A. Cost-effectiveness of IVF in women 38 years and older. Int J Gynecol Obstet 2000; 69: 143-8.
Toner J. Age=egg quality, FSH level=egg quantity. Fertil Steril 2003; 79: 491.
Scheffer JB, Scheffer BB, de Carvalho RF, et al. Age as a predictor of embryo quality regardless of the quantitative ovarian response. Int J Fertil Steril 2017; 11: 40-6.
McCoy RC, Demkok ZP, Ryan A, et al. Evidence of selection against complex mitotic-origin aneuploidy during preimplantation development. PLoS Genetics 2015; 22: 11.
Desquiret-Dumas V, Clement A, Seegers V, et al. The mitochondrial DNA content of cumulus granulosa cells is linked to embryo quality. Hum Reprod 2017; 32: 607-14.
Dechanet C, Castelli D, Reyftmann L, et al. Do female translocations influence the ovarian response pattern to controlled ovarian stimulation in preimplantation genetic diagnosis? Hum Reprod 2011; 25: 1232-40.
Keymolen K, Staessen C, Verpoest W, et al. A proposal for reproductive counselling in carriers of Roberstonian translocations: 10 years of experience with preimplantation genetic diagnosis. Hum Reprod 2009; 24: 2365-71.
Goossens V, Harton G, Moutou C, Traeger-Synodinos J, Van Rij M, Harper JC. ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. Human Reprod 2009; 24: 1786-810.
Kummer N, Marin JR, Pal L. Diminished ovarian reserve in a woman with a balanced 13;21 translocation. Fertil Steril 2009; 24: 2365-71.
Schlessinger D, Herrela L, Crisponi L, et al. Genes and translocations involved in POF. Am J Med Genet 2002; 111: 328-33.
Tsafrir A, Sltarescu G, Margolioth E, et al. PGD for fragile X syndrome: ovarian function is the main determinant of success. Hum. Reprod 2010; 25: 2629-36.
Huang J, Lian Y, Qiao J, Liu P. Clinical characteristics and preimplantation genetic diagnosis for male Robertsonian translocations. J Peking Univ (Health Sciences) 2012; 44: 544-6.
Eaker S, Pyle A, Cobb J, Handel MA. Evidence for meiotic spindle checkpoint from analysis of spermatocytes from Robertsonian-chromosome heterozygous mice. J Cell Sci 2001; 114: 2953-65.
Leng M, Li G, Zhong L, et al. Abnormal synapses and recombination in an azoospermic male carrier of a reciprocal translocation t(1;21). Feril Steril 2009; 91: 17-22.
Rao KL, Babu KA, Kanakavalli MK, Padmalatha VV, Deenadayal M, Singh L. Prevalence of chromosome defects in azoospermic and oligoastheno-teratozoospermic South Indian infertile men attending an infertility clinic. Reprod Biomed Online 2005; 10: 467-72.
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe